-+ 0.00%
-+ 0.00%
-+ 0.00%

Benchmark Maintains Buy on BlueLinx Hldgs, Lowers Price Target to $110

Benzinga·05/02/2025 14:59:06
Listen to the news
Benchmark analyst Reuben Garner maintains BlueLinx Hldgs (NYSE:BXC) with a Buy and lowers the price target from $120 to $110.